Company: SMNR
Filing Date: 2025-07-02
Form Type: S-4/A
Source: 0001193125-25-154936
Chunk: 1079

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-02
Form: S-4/A
Chunk 1079
---
ated by reference to Exhibit 4.2 of Denali’sForm S-1filed with the SEC on April 5, 2022).4.3Specimen Warrant Certificate of Denali Capital Acquisition Corp. (incorporated by reference to Exhibit 4.3 of Denali’s Form S-1 filed with the SEC on April 5, 2022).4.4Warrant Agreement, dated as of April 6, 2022, between Denali Capital Acquisition Corp. and VStock Transfer, LLC, as warrant agent (incorporated by reference to Exhibit 4.1 of Denali’s Current Report on Form 8-K filed with the SEC on April 12, 2022).5.1+Opinion of Winston & Strawn LLP regarding the validity of the securities.8.1+Opinion of Winston & Strawn LLP regarding tax matters.10.1Letter Agreement, dated as of April 6, 2022, by and among Denali Capital Acquisition Corp., Denali Capital Global Investments LLC and certain security holders named therein (incorporated by reference to Exhibit 10.5 of Denali’s Current Report onForm 8-Kfiled with the SEC on April 12, 2022).10.2Investment Management Trust Agreement, dated as of April 6, 2022, by and between Denali Capital Acquisition Corp. and Wilmington Trust, National Association, as trustee (incorporated by reference to Exhibit 10.1 of Denali’s Current Report on Form8-Kfiled with the SEC on April 12, 2022).II-2
| Exhibit 
 Number  
 10.3    
 10.4‡   |     | Description                                                                                                                                                                                                                                                                                                                                                                      
 Registration and Shareholder Rights Agreement, dated as of April 6, 2022, by and among Denali Capital Acquisition Corp., Denali Capital Global Investments LLC and certain security holders named therein (incorporated by reference to Exhibit 10.2 of Denali’s Current Report on Form 8-K filed with the SEC on April 12, 2022).                                               
 Second Amended and Restated Convertible Promissory Note, dated as of April 2, 2024, issued by Denali Capital Acquisition Corp. to Denali Capital Global Investments LLC.                                                                                                                                                                                                         |
|:--------|:----|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 10.5    |     | Convertible Prom